Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ketoreductase. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106566851B reveals a KRED-catalyzed route for Chloramphenicol. High purity, reduced cost, scalable manufacturing for global supply chains.
Novel engineered ketoreductase enables high optical purity synthesis of chiral intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN115341009B details enzyme solution reuse for steroid synthesis. Reduces cost and improves yield for pharmaceutical intermediates manufacturing supply chains.
Novel ketoreductase method for S-1-BOC-3 hydroxypiperidine ensures high purity and supply continuity. Reduce costs in API manufacturing with scalable enzymatic routes.
Patent CN106497996B reveals a high-ee enzymatic route for chiral alcohols. Discover cost reduction in pharmaceutical intermediates manufacturing and supply chain advantages.
Patent CN104805148A details a novel enzymatic route for (1R,2S)-N-pyrrolidyl norephedrine. This method eliminates controlled precursors, offering significant cost and supply chain advantages for API manufacturers.
Novel ketoreductase method for ezetimibe intermediate. Reduces cost, improves purity. Reliable supplier for pharma intermediates.
Discover advanced biocatalytic synthesis for ticagrelor intermediates using engineered ketoreductase. Achieve high substrate loading and cost reduction in pharmaceutical manufacturing.
Patent CN119823958A details a ketoreductase mutant for synthesizing chiral intermediates. This report analyzes supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN105567652A reveals high-purity (R)-HPBE synthesis via novel ketoreductase, offering significant cost reduction and supply chain reliability for ACE inhibitor manufacturing.
Patent CN111057725B reveals enzymatic synthesis for high-purity fungicide intermediates. Discover cost reduction and scalable supply chain solutions for Florylpicoxamid production.
Patent CN102965403A reveals a novel recombinant ketoreductase method for statin side chains, offering superior purity and simplified downstream processing for pharmaceutical manufacturers.
Patent CN110964703B reveals high-efficiency ketoreductase for duloxetine intermediate. Achieve cost reduction and supply reliability in pharmaceutical manufacturing.
Patent CN102482648B details stereoselective reduction enhancing supply chain reliability and purity for pharmaceutical manufacturing.
Novel ketoreductase mutant enables high-purity pharmaceutical intermediates manufacturing with substantial cost reduction and enhanced supply chain reliability for global partners.
Advanced enzymatic synthesis of levocarnitine via patent CN118879801B offers high yield and supply chain stability for global pharmaceutical manufacturers.
Patent CN110257351A reveals high-activity enzyme mutants for chiral alcohol synthesis offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN116179502A details a novel ketoreductase mutant enabling >99% ee chiral alcohol synthesis. Discover cost-effective biocatalytic solutions for pharmaceutical manufacturing.
Patent CN115537405B reveals a high-efficiency ketoreductase mutant for producing chiral pharmaceutical intermediates with superior selectivity and scalable manufacturing potential.
Patent CN109797174B reveals high-yield ketoreductase route. Reduces heavy metal waste, ensures 100% ee. Ideal for veterinary API supply chains.